4/2
07:30 am
inkt
MiNK Therapeutics to Present New Data at ASGCT 2026 Highlighting Context-Dependent Activity of iNKT Cell Therapy
Low
Report
MiNK Therapeutics to Present New Data at ASGCT 2026 Highlighting Context-Dependent Activity of iNKT Cell Therapy
4/1
08:01 am
inkt
MiNK Therapeutics (INKT) had its "buy" rating reaffirmed by HC Wainwright. They now have a $35.00 price target on the stock.
Low
Report
MiNK Therapeutics (INKT) had its "buy" rating reaffirmed by HC Wainwright. They now have a $35.00 price target on the stock.
4/1
07:48 am
inkt
MiNK Therapeutics Announces Abstract Acceptance for Presentation at the American Thoracic Society (ATS) 2026 International Conference [TheStreet.com]
Low
Report
MiNK Therapeutics Announces Abstract Acceptance for Presentation at the American Thoracic Society (ATS) 2026 International Conference [TheStreet.com]
4/1
07:45 am
inkt
MiNK Therapeutics Announces Abstract Acceptance for Presentation at the American Thoracic Society (ATS) 2026 International Conference [Yahoo! Finance]
Low
Report
MiNK Therapeutics Announces Abstract Acceptance for Presentation at the American Thoracic Society (ATS) 2026 International Conference [Yahoo! Finance]
4/1
07:30 am
inkt
MiNK Therapeutics Announces Abstract Acceptance for Presentation at the American Thoracic Society (ATS) 2026 International Conference
Medium
Report
MiNK Therapeutics Announces Abstract Acceptance for Presentation at the American Thoracic Society (ATS) 2026 International Conference
3/31
03:22 pm
inkt
MiNK Therapeutics Inc (INKT) Q4 2025 Earnings Call Highlights: Strategic Advances and Financial ... [Yahoo! Finance]
Low
Report
MiNK Therapeutics Inc (INKT) Q4 2025 Earnings Call Highlights: Strategic Advances and Financial ... [Yahoo! Finance]
3/31
09:44 am
inkt
MiNK Therapeutics Q4 Earnings Call Highlights [Yahoo! Finance]
Low
Report
MiNK Therapeutics Q4 Earnings Call Highlights [Yahoo! Finance]
3/31
07:30 am
inkt
MiNK Therapeutics Reports Q4 and Full Year 2025 Results; Phase 2 Programs Advance with Impactful Non-Dilutive Momentum
Low
Report
MiNK Therapeutics Reports Q4 and Full Year 2025 Results; Phase 2 Programs Advance with Impactful Non-Dilutive Momentum
3/31/2026
07:30 am
INKT
mink therapeutics, inc.
BEAT
Report
-2.6%
mink therapeutics, inc.
11/14/2025
07:30 am
INKT
mink therapeutics, inc.
BEAT
Report
-0.6%
mink therapeutics, inc.
8/14/2025
07:30 am
INKT
mink therapeutics, inc.
MISS
Report
-9.9%
mink therapeutics, inc.
5/15/2025
07:30 am
INKT
mink therapeutics, inc.
MISS
Report
-8.8%
mink therapeutics, inc.
3/31
04:49 pm
inkt
Form 10-K MiNK Therapeutics, Inc. For: Dec 31
Low
Report
Form 10-K MiNK Therapeutics, Inc. For: Dec 31
3/31
08:07 am
inkt
Form 8-K MiNK Therapeutics, Inc. For: Mar 31
Medium
Report
Form 8-K MiNK Therapeutics, Inc. For: Mar 31
3/27
10:40 am
inkt
Form 8-K MiNK Therapeutics, Inc. For: Mar 27
Low
Report
Form 8-K MiNK Therapeutics, Inc. For: Mar 27
3/23
04:30 pm
inkt
Form 3 MiNK Therapeutics, Inc. For: Mar 13 Filed by: Charette Austin
Low
Report
Form 3 MiNK Therapeutics, Inc. For: Mar 13 Filed by: Charette Austin
3/19
05:21 pm
inkt
Form 8-K MiNK Therapeutics, Inc. For: Mar 13
Low
Report
Form 8-K MiNK Therapeutics, Inc. For: Mar 13
3/11
06:22 pm
inkt
Form 4 MiNK Therapeutics, Inc. For: Mar 09 Filed by: Ryan Barbara
Medium
Report
Form 4 MiNK Therapeutics, Inc. For: Mar 09 Filed by: Ryan Barbara
3/4
04:45 pm
inkt
Form 4 MiNK Therapeutics, Inc. For: Feb 27 Filed by: Ryan Barbara
Low
Report
Form 4 MiNK Therapeutics, Inc. For: Feb 27 Filed by: Ryan Barbara
1/14
04:05 pm
inkt
Form 4/A MiNK Therapeutics, Inc. For: Jan 02 Filed by: Buell Jennifer
Low
Report
Form 4/A MiNK Therapeutics, Inc. For: Jan 02 Filed by: Buell Jennifer
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register